Christopher E. Diamantis - Aug 27, 2021 Form 4 Insider Report for Rennova Health, Inc. (RNVA)

Role
10%+ Owner
Signature
/s/ Christopher E. Diamantis
Stock symbol
RNVA
Transactions as of
Aug 27, 2021
Transactions value $
$0
Form type
4
Date filed
9/27/2021, 05:15 PM
Next filing
Sep 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNVA Common Stock Other +95M +21111.11% 95.5M Aug 27, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNVA Warrants to Purchase Common Stock Other +47.5M 47.5M Aug 27, 2021 Common Stock 47.5M $0.01 Direct F1, F2
transaction RNVA Series M Convertible Redeemable Preferred Stock Other -570 -2.75% 20.2K Aug 27, 2021 Common Stock Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 27, 2021, pursuant to the terms of an Exchange Agreement with the Issuer, Mr. Diamantis exchanged 570 shares of Series M Redeemable Convertible Preferred Stock of the Issuer (the "Series M Preferred Stock") for 95,000,000 shares of Common Stock and Warrants to purchase 47,500,000 shares of Common Stock.
F2 The exercise of the Warrants and the conversion of the Series M Preferred Stock are each subject to ownership blockers of 4.99%. As a result, they are not exercisable or convertible as of August 27, 2021. The Series M Preferred Stock has no stated maturity date.
F3 The conversion price of the Series M Preferred Stock fluctuates with the price of the Common Stock.